The proliferation of cells in vivo and in culture is regulated by polypeptide growth factors, such as epidermal growth factor (EGF) and platelet-derived growth factor (PDGF). Growth factors initiate their action by binding to specific cell surface receptors. Receptor occupancy triggers a cascade of physiological changes in the target cell which ultimately lead to DNA synthesis and cell division. Immediate consequences of receptor activation include tyrosine-specific protein phosphorylations, a sustained increase in cytoplasmic pH (pH,) and a transient rise in free Ca2+. The rise in pH, has a permissive effect on DNA synthesis and is mediated by an otherwise quiescent Na+/H+ exchange mechanism in the plasma membrane, which is turned on by protein kinase C, the cellular receptor for phorbol esters. The rapid Ca2+ signal is due to either release from internal stores (PDGF) or net entry via a voltage-independent channel in the plasma membrane (EGF). Phorbol esters, acting via kinase C, inhibit the growth factor-induced Ca2+ signals without affecting resting Ca2+ levels.

Monoclonal antibodies against the human EGF receptor can act as partial agonists in that they activate the tyrosine-specific protein kinase without inducing any of the ionic signals. These antibodies fail to induce DNA synthesis when added to quiescent fibroblasts, indicating that the Ca2+ and pH, signals can be dissociated from tyrosine kinase activity and suggesting that these signals are indispensable for the stimulation of cell proliferation.

Growth factors are polypeptide hormones that induce replicative DNA synthesis and cell division in their target cells. Like all polypeptide hormones, growth factors initiate their action by binding to specific, high-affinity receptor molecules on the cell surface. Although much has been learned about growth factor-receptor interaction, the molecular mechanisms of action and the in vivo functions of growth factors are poorly understood. A number of growth factors have been purified to homogeneity and their primary structure has been solved, at least in large part. By far the most extensively studied growth factors are epidermal growth factor (EGF) and platelet-derived growth factor (PDGF). EGF is a single polypeptide chain (relative molecular mass, Mr, 6045), routinely isolated from the mouse submaxillary gland, that stimulates the proliferation of epithelial cells in vivo and of various additional cell types in culture (Carpenter & Cohen, 1979). PDGF is a highly basic glycoprotein (Mr, 30 000–33 000) that is released from platelets during blood clotting and at sites of blood vessel injury, where it may serve to promote wound healing by stimulating the migration and proliferation of fibroblasts, glial cells and smooth muscle cells (Westermarkei al. 1983). Interest in these mitogens and their receptors has been dramatically intensified by the discovery that at least some of these molecules show a striking structural homology with certain viral oncogene products: the sis oncogene encodes a PDGF-like molecule (Doolittle et al. 1983; Waterfield et al. 1983), while the erb-B oncogene product is a truncated form of the EGF receptor (Downward et al. 1984). Inappropriate expression of the cellular counterparts of viral oncogenes is thought to be responsible for the initiation and maintenance of malignant growth. Therefore, the study of the mode of action of EGF and PDGF will undoubtedly provide important insights into the mechanisms underlying carcinogenesis.

Understanding the mode of action of growth factors requires the identification of intracellular signals that are essential for the stimulation of DNA synthesis and cell division. The intention of this short review is to focus on the generation of ionic signals by growth factors with emphasis on the activation of Na+/H+ exchange and the mobilization of Ca2+. Furthermore, we will describe some of the approaches to assess the interrelationship between the various signal pathways, such as the use of tumour-promoting phorbol esters and monoclonal antibodies against the EGF receptor.

Following growth factor binding, the activated receptor mediates a cascade of rapid biochemical and physiological changes in the cell, which ultimately (after 10–20 h) lead to the stimulation of DNA synthesis. As a rule, the growth factor has to be present throughout the entire ‘pre-replicative’ phase (usually >8–10 h) for commitment to DNA synthesis to occur. It turns out that there are at least three potential signal pathways in the action of growth factors like EGF and PDGF (Fig. 1).

Fig. 1.

Potential signalling pathways in the action of growth factors.

Fig. 1.

Potential signalling pathways in the action of growth factors.

One of the first consequences of growth factor-receptor interaction is the activation of a protein kinase specific for tyrosyl residues (Carpenter, 1984; Heldin & Westermark, 1984; Hunter & Cooper, 1985). In fact, the receptors for growth factors like EGF and PDGF are transmembrane glycoproteins that possess intrinsic tyrosine-specific protein kinase activity (Hunter & Cooper, 1985). Growth factor binding induces a rapid stimulation of the receptor kinase, resulting in autophosphorylation of the receptor itself as well as in the phosphorylation of various substrate proteins. The intrinsic tyrosine-specific kinase activity is shared with several viral oncogene products, such as the transforming protein of Rous sarcoma virus (Bishop, 1985). This suggests that tyrosine-specific protein phosphorylations may initiate a set of common mitogenic pathways in virus-transformed and growth factor-stimulated cells. However, it is not yet possible to relate increased tyrosine kinase activity to specific metabolic alterations in stimulated cells.

Other immediate consequences of receptor activation (Fig. 1) include the breakdown of inositol phospholipids (Sawyer & Cohen, 1981; Berridge, Heslop, Irvine & Brown, 1984), a transient rise in cytoplasmic free Ca2+ ([Ca2+]i) (Moolenaar, Tertoolen & de Laat, 1984; Moolenaar, Aerts, Tertoolen & de Laat, 1986) and the stimulation of monovalent ion transport across the plasma membrane (Rozengurt, 1981; Moolenaar, 1986a). Of the known ionic transport changes in growth factor-stimulated cells, the activation of electroneutral Na+/H+ exchange is best characterized (see next section).

A few studies have focused on the electrical membrane properties of stimulated cells. Using conventional electrophysiological techniques, Hülser & Frank (1971) and Moolenaar, Yarden, de Laat & Schlessinger (1982) showed that serum growth factors, when added to quiescent fibroblasts, elicit an immediate but transient membrane depolarization from about –60 mV to –15 mV, apparently due to a large increase in monovalent ion conductance. A qualitatively similar electrophysiological effect was observed in serum-stimulated neuroblastoma cells (Moolenaar, de Laat & van der Saag, 1979). Whether this sudden ionic ‘leakiness’ of the plasma membrane is caused by a mitogen-induced phosphorylation reaction is not known; nor is it known which serum component is responsible for this effect, although thrombin is a strong candidate (W. H. Moolenaar, unpublished data).

While EGF can mimic serum in eliciting a transient membrane depolarization in an epithelial cell line (Rothenberg, Reuss & Glaser, 1982), the available evidence nevertheless indicates that rapid changes in ionic conductance and membrane potential are not a general phenomenon accompanying EGF receptor binding (cf. Moolenaar et al. 1982, 1986). It therefore appears that changes in ionic conductance, although interesting in their own right, are not essential for the generation of a mitogenic signal by growth factors.

The first direct evidence that growth factors activate an otherwise quiescent Na+/H+ exchanger in the plasma membrane came from studies on serum-stimulated neuroblastoma cells (Moolenaar, Boonstra, van der Saag & de Laat, 1981a; Moolenaar, Mummery, van der Saag & de Laat, 1981b). Re-addition of serum to growth-arrested cells leads to the rapid activation of an electrically silent Na+ influx pathway, which is sensitive to amiloride and can be stimulated by acidifying the cytoplasm using weak acids. In addition, it was shown that amiloride-sensitive Na+ uptake in such acid-loaded cells is coupled to the efflux of H+ with a 1:1 stoichiometry. In a subsequent study it was shown that EGF-induced Na+ influx in quiescent human fibroblasts is amiloride-sensitive, electroneutral and is enhanced by cytoplasmic acid loads (Moolenaar et al. 1982). From these studies it was predicted that stimulation by mitogens would lead to an increase in pHi, while the accompanying entry of Na+ would result in a stimulation of the Na+,K+-pump. New developments in pHi-monitoring techniques, particularly the synthesis of fluorescent indicators that can be trapped into the cytoplasm of small cells, have demonstrated that the Na+/H+ exchanger is normally involved in the close regulation of pHi and that activation of the Na+/H+ exchanger by growth factors leads to a sustained rise in pHi of 0·2–0·3 units.

Most cells maintain their pH1, at 7·0–7·4. This is well above the electrochemical equilibrium value of 6·0–6·4 that is predicted by the Nernst equation from a transmembrane potential of approximately –60 mV. In vertebrate cells, the specific H+-extruding mechanism which raises pH, appears to be a Na+/H+ exchange (Roos & Boron, 1981; Moolenaar, 1986b). The functioning of the Na+/H+ exchanger in the plasma membrane and its role in pH, homeostasis is most easily assessed by continuously monitoring the rapid recovery of pHi to its resting level after a sudden acidification of the cytoplasm, as induced by a NH4+-prepulse or by weak acids (Roos & Boron, 1981). In most cells, this pHi recovery process follows an exponential time course and is entirely due to net H+ extrusion via the Na+/H+ exchanger, which utilizes the energy stored in the transmembrane Na+ gradient. The major determinant of the rate of the Na+/H+ exchanger is pHi. At normal pHi values (near 7·0) the exchanger is relatively inactive, although the steep transmembrane Na+ gradient could theoretically raise pHi by about one unit.

As pH, falls below a certain ‘threshold’, the Na+/H+ exchanger is increasingly stimulated. Aronson and coworkers (Aronson, Nee & Suhm, 1982) were the first to point out that the Na+/H+ exchanger is apparently set in motion through an allosteric activation by cytoplasmic H+ at a regulatory site which is distinct from the internal H+ transport binding site. The relatively strong pHi sensitivity of the exchanger is, of course, a crucial property for an H+-extruding system to maintain pHi at a critical level. Furthermore, a change in the apparent affinity of the exchanger for internal H+ would provide a powerful mechanism by which external stimuli could regulate the physiological state of the exchanger.

The diuretic amiloride reversibly inhibits Na+/H+ exchange, apparently by competing with Na+ for binding to the same external site (Ki: 2–5 μmol l−1). Several amiloride analogues have been found to be 10–100 times more potent than amiloride in blocking Na+/H+ exchange (L’Allemain, Franchi, Cragoe & Pouysségur, 1984; Zhuang et al. 1984). It should be noted, however, that amiloride and its potent analogues are taken up by most cells in culture and thereby may affect cellular functions such as protein synthesis and kinase activity (Zhuang et al. 1984; Besterman et al. 1985; Davis & Czech, 1985).

Fig. 2 shows a typical example of an alkaline pH, shift after addition of EGF to quiescent cells loaded with the pH-sensitive dye bis(carboxyethyl)carboxy-fluorescein (BCECF). The shift in pH, is initiated within 20–30s and is complete by 10–15 min. The elevated pHi persists for as long as the growth factor is present. In general, the induced alkalinizations range from 0·1–0·3. pH units; they are inhibited by amiloride and by Na+ removal and are accompanied by a transient increase in amiloride-sensitive 22Na+ uptake (Fig. 1; for review see Moolenaar, 1986a). Furthermore, the rise in pHi is converted into a fall in pHi when the direction of the transmembrane Na+ gradient is reversed (Moolenaar, Tsien, van der Saag & de Laat, 1983). When taken together, these data convincingly demonstrate that the mitogen-induced pHi rise is mediated by the Na+/H+ exchanger.

Fig. 2.

Activation of Na+/H+ exchange by epidermal growth factor (EGF) in human fibroblasts. Upper panel: shift in pH, induced by EGF (l0 ng ml−1). Quiescent monolayers were loaded with bis(carboxyethyl)carboxyfluorescein (BCECF) as described (Moolenaar, Tsien, van der Saag & de Laat, 1983). Lower panel: time course of EGF-induced 22Na+ uptake in the presence (▫) and absence (●) of 1 mmol l−1 amiloride. Initial rates of 22Na+ uptake were measured over 3-min intervals in the presence of 0·1 mmol l−1 ouabain to block active Na+ efflux.

Fig. 2.

Activation of Na+/H+ exchange by epidermal growth factor (EGF) in human fibroblasts. Upper panel: shift in pH, induced by EGF (l0 ng ml−1). Quiescent monolayers were loaded with bis(carboxyethyl)carboxyfluorescein (BCECF) as described (Moolenaar, Tsien, van der Saag & de Laat, 1983). Lower panel: time course of EGF-induced 22Na+ uptake in the presence (▫) and absence (●) of 1 mmol l−1 amiloride. Initial rates of 22Na+ uptake were measured over 3-min intervals in the presence of 0·1 mmol l−1 ouabain to block active Na+ efflux.

How does receptor occupancy lead to activation of the Na+/H+ exchanger? Recent studies have shown that the activation is attributable to an alkaline shift in the pH, sensitivity of the exchanger (Moolenaar et al. 1983; Paris & Pouysségur, 1984; Grinstein et al. 1985). As mentioned above, this pHi sensitivity is determined by an allosteric H+-binding site on the cytoplasmic face of the exchanger. It thus seems plausible to assume that the altered pHi sensitivity of the exchanger is due to some conformational change resulting in an increased pKa of the regulatory H+-binding site. Thus, the physiological effect of growth factors on the Na+/H+ exchanger is to increase its pHi threshold, that is the level to which pHi must rise before the exchanger virtually shuts off. Indeed, the Na+/H+ exchanger is only transiently stimulated by external stimuli and its activity returns to the control level once pHi has attained its new stable value (Fig. 2; Moolenaar, 1986a).

The obvious next question is by which route growth factors modify the pH1 sensitivity of the exchanger to raise pHi. An important key comes from studies using the tumour promotor 12-O-tetradecanoyl-13-acetate (TPA), which binds to and directly activates the phospholipid-dependent protein kinase C (Nishizuka, 1984). Under normal conditions, kinase C is activated by endogenous diacylglycérol (DG) derived from the breakdown of inositol phospholipids. Both TPA and synthetic DG are capable of mimicking the effects of growth factors on Na+/H+ exchange and pHi in various cell types (reviewed by Moolenaar, 1986a). The simplest explanation for these findings is that kinase C directly phosphorylates the exchanger, but it cannot, of course, be excluded that kinase C acts in a more indirect way to activate Na+/H+ exchange. Information concerning the molecular structure of the exchange carrier may become available in the near future, and this should greatly facilitate further study of the role of kinase C and other kinases in the activation process.

The apparent involvement of kinase C strongly suggests that an alkaline shift in pHi is not uniquely induced by growth factors and phorbol esters but may be a common cellular response in the action of those hormones and neurotransmitters that trigger the hydrolysis of inositol phospholipids and thereby generate diacylglycerol. There is some evidence to support this notion: in typical model systems of hormone-induced phosphoinositide turnover, such as platelets and neutrophils, the pHi rises rapidly after activation by physiological stimuli (Molskiel al. 1980; Horne, Norman, Schwartz & Simons, 1981).

Finally, it is noteworthy that there is evidence, albeit circumstantial, that pathways other than kinase C may be involved in Na+/H+ exchange activation (Vara & Rozengurt, 1985; Paris & Pouysségur, 1986). The biochemical nature of these pathways remains to be elucidated.

In addition to activating Na+/H+ exchange, mitogens like EGF and PDGF induce a rapid but transient rise in [Ca2+]1 in their target cells, as measured by quin-2 fluorescence (Moolenaar et al. 1983, 1986; Hesketh et al. 1985). The best characterized example of a mitogen-induced [Ca2+]i rise comes from PDGF-treated fibroblasts (Berridge et al. 1984; Moolenaar et al. 1984). Addition of PDGF to quiescent fibroblasts elicits an approximately twofold rise in [Ca2+]i which is initiated without a detectable lag period and is usually complete within 30–60 s. Thereafter, [Caz+]i gradually returns to near-basal levels over a 10-to 15-min period. Fig. 3 schematically illustrates the time courses of both the [Ca2+]i transient and the rise in pH, as induced by EGF in responsive cells.

Fig. 3.

Changes in [Ca]i and pHi in human A431 cells following the addition of epidermal growth factor (EGF) (100 ng ml−1). For methods see Moolenaar, Tsien, van der Saag & de Laat (1983) and Moolenaar, Aerts, Tertoolen & de Laat (1986).

Fig. 3.

Changes in [Ca]i and pHi in human A431 cells following the addition of epidermal growth factor (EGF) (100 ng ml−1). For methods see Moolenaar, Tsien, van der Saag & de Laat (1983) and Moolenaar, Aerts, Tertoolen & de Laat (1986).

How does growth factor binding increase [Ca2+]i? The Ca2+ signal in response to PDGF is not prevented by removal of external Ca2+, indicating that the Ca2+ is released from intracellular stores, presumably the endoplasmic reticulum (Moolenaar et al. 1984). Indeed, PDGF provokes the rapid formation of inositol-1,4,5-trisphosphate (IP3), the key messenger for mobilizing Ca2+ from non-mitochondrial stores (Berridge et al. 1984; Berridge & Irvine, 1984). Surprisingly, the Ca2+ signal in response to EGF shows no contribution from intracellular stores but seems to result from net Ca2+ entry through a voltage-independent Ca2+ channel in the plasma membrane (Moolenaar et al. 1986). This interpretation is based on the finding that the EGF-induced [Ca2+]i rise in human A431 carcinoma cells is critically dependent on the extracellular Ca2+ concentration, is accompanied by enhanced 45Ca2+ uptake (Sawyer & Cohen, 1981), is blocked by Ca2+ entry blockers like La3+ and Mn2+, while it is not accompanied by changes in transmembrane potential. Since EGF is known to stimulate phosphoinositide turnover and diacylglycerol formation in A431 cells (Sawyer & Cohen, 1981; Sahai, Smith, Pannerselvam & Salomon, 1982), it is intriguing that EGF does not seem to act on intracellular stores to raise [Ca2+]i.

What could be the molecular nature of the putative Ca2+ channel that is activated when EGF binds to its receptor? An attractive candidate for mediating Ca2+ entry is phosphatidic acid, an anionic phospholipid that is rapidly formed from diacylglycerol in EGF-treated A431 cells (Sawyer & Cohen, 1981) and that may function as a Ca2+ ionophore in model systems (Serhan et al. 1982) and in intact cells from various tissues (Putney, Weiss, van der Walle & Haddas, 1980; Ohsako & Deguchi, 1981). Our preliminary experiments (unpublished) indeed indicate that exogenous phosphatidate can transiently elevate [Ca2+]i in A431 cells. On the other hand, the absolute requirement for external Ca2+ could, of course, simply reflect a Ca2+dependent coupling of individual EGF receptors to the IP3-generating process. Further characterization of phosphoinositide metabolism in EGF-treated A431 cells is therefore eagerly awaited.

Unlike the mitogen-induced pH; shift, the rise in [Ca2+]i cannot be mimicked by phorbols ester like TPA (Moolenaar et al. 1984, 1986), consistent with the notion that TPA acts at a point (kinase C) distal from Ca2+ mobilization. This result demonstrates that both ionic signals are dissociable and can occur independently of each other.

There is growing evidence that TPA, acting via protein kinase C, not only stimulates cellular functions but also has a negative feedback role in that it can shut off certain intracellular signal pathways in the action of growth factors and hormones. For example, phosphorylation of the EGF receptor by kinase C appears to decrease its EGF-stimulated tyrosine kinase activity (Hunter & Cooper, 1985). Furthermore, TPA has been shown to inhibit both the EGF-stimulated Na+/H+ exchange (Whiteley, Cassel, Zhuang & Glaser, 1984) and the [Ca2+]i rise in A431 cells (Moolenaar et al. 1986). In TPA-treated 3T3 cells, the Ca2+ signal in response to EGF is also completely blocked (Hesketh et al. 1985). TPA also causes the closure of antigen-activated Ca2+ channels in the plasma membrane of basophils (Sagi-Eisenberg, Lieman & Pecht, 1985). The molecular mechanism underlying these inhibitory effects of TPA is not precisely known, although it is becoming increasingly apparent that the receptor-linked breakdown of phosphoinositides is strongly suppressed once kinase C is activated.

By which mechanism does kinase C inhibit phosphoinositide hydrolysis? It has been proposed that a novel GTP-binding protein (Gp or Np; see Cockroft & Gomperts, 1985) is involved in coupling hormone receptors to phospholipase C and phosphoinositide breakdown. Interestingly, it has been reported that kinase C can phosphorylate a GTP-binding protein (Gi/Ni) and thereby inhibit its regulatory function (Katada et al. 1985). It is an attractive hypothesis that Gp may also serve as a physiological substrate for protein kinase C and that its presumed function in phospholipase C stimulation is impaired by its phosphorylation. Whatever the nature of the phosphorylated substrate(s), it appears that protein kinase C functions to uncouple certain growth factor receptors from their second-messenger generating systems. Perhaps this represents a mechanism whereby phorbol esters like TPA exert their tumour-promoting effects.

The partial activation of post-receptor signalling pathways by phorbol esters has proved to be a fruitful approach in elucidating interrelationships among these pathways. An alternative tool for the dissociation of molecular events in the signalling cascade is provided by the availability of monoclonal antibodies to the EGF receptor. We have used three different anti-EGF receptor monoclonal IgGs, directed against distinct epitopes of the extracellular domain of the human EGF receptor (Defize, Moolenaar, van der Saag & de Laat, 1986), to test their ability to act as partial or full agonists of the EGF receptor. All three antibodies (named 2E9, 2D 11 and 2G5, respectively) are able to immunoprecipitate a functional EGF receptor showing EGF-dependent tyrosine kinase activity. Monoclonal 2E9 is unique in that it recognizes a peptide determinant at or close to the EGF binding domain of the receptor. As a consequence, 2E9 competitively inhibits EGF receptor binding. In contrast, the other monoclonals (2D 11 and 2G5) are directed to bloodgroup A-specific carbohydrate structures on the EGF receptor and fail to affect EGF binding. We have tested these antibodies for their EGF-like properties in stimulating the receptor-mediated tyrosine phosphorylations, cytoplasmic alkalinization, Ca2+ mobilization and DNA synthesis. As summarized in Table 1, all three monoclonal IgGs can stimulate the tyrosine-specific autophosphorylation of the 170 kD EGF receptor both in isolated A431 membranes and in intact cells (Defize, Moolenaar, van der Saag & de Laat, 1986). Interestingly, none of these antibodies is capable of triggering a rise in [Ca2+]i and inducing cytoplasmic alkalinization (Table 1), even after addition of a second cross-linking anti-IgG. Finally, the anti-receptor antibodies fail to stimulate DNA synthesis in quiescent human fibroblasts. Stimulation of the receptor’s intrinsic tyrosine kinase is apparently not sufficient, by itself, to elicit a mitogenic response (for further details see Defize, Moolenaar, van der Saag & de Laat, 1986). Another important conclusion from those results is that stimulation of the EGF receptor kinase does not necessarily activate the post-receptor pathway that leads to an increase in [Ca2+]i and in pHi. These findings further support the view that the two major ionic signals are indispensable for the stimulation of DNA synthesis and cell proliferation.

Table 1.

Comparison of the biological effects, of EGF and anti-EGF receptor monoclonal antibodies on human A431 cells and fibroblasts

Comparison of the biological effects, of EGF and anti-EGF receptor monoclonal antibodies on human A431 cells and fibroblasts
Comparison of the biological effects, of EGF and anti-EGF receptor monoclonal antibodies on human A431 cells and fibroblasts

Cytoplasmic alkalinization

An early rise in pHi appears to be a fairly common response of metabolically dormant cells to appropriate surface stimuli. Several lines of evidence support the hypothesis that a sustained increase in pHi mediated by the Na+/H+ exchanger, may be required for mitogenesis. Perhaps the clearest demonstration of a role for cytoplasmic alkalinization in the initiation of a mitogenic response comes from studies on fertilized sea urchin eggs, where it has been shown that pHi must rise from 6·8 to above 7·0 to permit DNA synthesis to begin (Whitaker & Steinhardt, 1982). One of the critical pHi-dependent steps in the fertilized eggs appears to be the stimulation of protein synthesis. From studies on somatic cells it is known that pHi may participate in the regulation of such diverse processes as glycolosis, cell-to-cell communication and cytoskeletal reorganization (reviewed by Busa & Nuccitelli, 1984).

Fig. 4 shows the effects of artificially shifting pH, on the ability of quiescent human fibroblasts to reinitiate DNA synthesis in the presence of serum. It is seen that below a certain threshold value (near 7·0) pHi becomes limiting for DNA synthesis, but that thymidine incorporation dramatically increases between pHi 7·0–7·2. It is also observed that an artificially induced rise in pHi is not sufficient, in itself, to stimulate DNA synthesis in serum-deprived cells (Fig. 4). These results agree, at least qualitatively, with earlier observations in thrombin-stimulated hamster fibroblasts: using mutant cells that lack a functional Na+/H+ exchanger, Pouysségur et al. (1984) and Pouysségur, Franchi, l’Allemain & Paris (1985) elegantly showed that the initiation of DNA synthesis in mitogen-stimulated cells is extremely sensitive to pH1 At pHi < 7·2, DNA synthesis is completely blocked, but the mutant cells resume growth as soon as their pHi is artificially elevated, either by raising external pH or incubating them in bicarbonate-buffered media. Addition of bicarbonate apparently raises pHi into the ‘permissive range’ due to the operation of a Na+-dependent HCO3/Cl exchanger (l’Allemain, Paris & Pouysségur, 1985).

Fig. 4.

Dependence of DNA synthesis on pH, in human fibroblasts. Growth-arrested fibroblasts were incubated in Hepes-buffered media in the presence (●) or absence (▫) of serum (10% v/v) and their pHi was adjusted to the indicated values (by changing extracellular pH) for a period of 20 h. Thereafter, [3H] thymidine (1 μCi ml−1) was added at physiological external pH (7·4) and acid-insoluble counts were determined after 24 h.

Fig. 4.

Dependence of DNA synthesis on pH, in human fibroblasts. Growth-arrested fibroblasts were incubated in Hepes-buffered media in the presence (●) or absence (▫) of serum (10% v/v) and their pHi was adjusted to the indicated values (by changing extracellular pH) for a period of 20 h. Thereafter, [3H] thymidine (1 μCi ml−1) was added at physiological external pH (7·4) and acid-insoluble counts were determined after 24 h.

Increases in pHi during the cell cycle have been observed in a few different cell types. In the slime mould, Physarum, pHi rises rapidly just before mitosis whereas in Tetrahymena there are two alkaline pHi transients per cell cycle (Busa & Nuccitelli, 1984). In the cellular slime mould Dictyostelium discoideum there is a cycle of pHi that closely corresponds to the DNA replication cycle, with a peak during S phase and mitosis (Aerts, Durston & Moolenaar, 1985). Interestingly, when protein and DNA synthesis are blocked, pHi continues to oscillate with a similar period as in the uninhibited division cycle. Conversely, an artificial increase in pHi by only 0·1 unit causes a several-fold increase in the rates of protein and DNA synthesis. It was concluded that this autonomous ‘pH, oscillator’ may have an important role in the timing and regulation of the cell cycle (Aerts et al. 1985). It was further hypothesized that the observed pHi cycles are due to periodic alterations in the activity of a plasma membrane H+ pump, probably an H+-ATPase. Obviously, it would be of great interest to determine whether pHi regulated by Na+/H+ exchange exhibits similar oscillations during the cell cycle of higher eukaryotes.

In summary, the available evidence provides strong support for the view that pHi plays an important role in the regulation of cellular metabolism in general and in the regulation of DNA synthesis and cell proliferation in particular.

Rise in [Ca2+]i

Another key question is what the physiological role of the [Ca2+]i transient is in the action of growth factors. Numerous cellular functions are regulated by [Ca2+]i and many of them through the formation of Ca2+-calmodulin complexes. A discussion on this topic is beyond the scope of this brief review. Of particular relevance to mitogen action is the finding that artificially raising [Ca2+]1 using the Ca2+ ionophore A23187, can mimic the effects of EGF and PDGF on the rapid induction of the c-fos and c-myc proto-oncogenes (Bravo, Burckhardt, Curran & Müller, 1985; Tsuda, Kaibuchi, West & Takai, 1985). We recently found that Ca2+-mobilizing neurohormones like bradykinin and histamine similarly induce c-fos and c-rnyc expression as well as cell division in their target cells (W. Kruijer & W. H. Moolenaar, unpublished data). These results raise the intriguing possibility that Ca2+ could function as a second messenger that mediates, either directly or indirectly, the early transcriptional effects of growth factors and some hormones. In addition, they provide a framework for future studies on the role of intracellular Ca2+ in growth control.

In recent years much has been learned about the various molecular events that are induced by growth factor-receptor interaction. These include tyrosine-specific protein phosphorylations, inositol phospholipid breakdown and the two major ionic events discussed above, namely, transient elevation of [Ca2+], and activation of Na+/H+ exchange resulting in a sustained rise in pHi. There is good evidence that both ionic events are the direct consequence of the receptor-mediated hydrolysis of inositol phospholipids, while tyrosine kinase activity seems to initiate a distinct pathway, as summarized in the scheme of Fig. 5. Although uncertainty still exists about the biological significance of each of these ‘early’ steps in the eventual initiation of DNA synthesis, occurring many hours later, it seems likely that the various events evoked by inositol phospholipid breakdown act in concert with tyrosine-specific protein phosphorylations to stimulate cell proliferation. Selective pharmacological inhibitors without non-specific side effects could greatly assist in elucidating the relevance of each of the signal pathways, but such agents are lacking at present. It is obvious that mutant cells defective in Na+/H+ exchange activity (Pouysségur et al. 1984, 1985) or other functions, as well as anti-receptor monoclonal antibodies that act as partial agonists (Defize, Moolenaar, van der Saag & de Laat, 1986) are of enormous help in analysing the role of the various signal pathways in growth control.

Fig. 5.

Proposed sequence of events leading from growth factor binding to ionic signals. Gp is the putative GTP-binding protein; Tyr-kinase, tyrosine-specific protein kinase; PLase C, phospholipase C; PIPz, phosphatidylinositol 4,5-bisphosphate; DG, 1,2-diacylglycerol; IP3, inositol 1,4,5-trisphosphate; TPA, 12-O-tetradecanoyl phorbol-13-acetate. Note that there is a fundamental difference between the [Ca2+],-raising mechanism of platelet-derived growth factor (PDGH) (via IP3) and that of epidermal growth factor (EGF) (via Ca2+ entry). See text for details.

Fig. 5.

Proposed sequence of events leading from growth factor binding to ionic signals. Gp is the putative GTP-binding protein; Tyr-kinase, tyrosine-specific protein kinase; PLase C, phospholipase C; PIPz, phosphatidylinositol 4,5-bisphosphate; DG, 1,2-diacylglycerol; IP3, inositol 1,4,5-trisphosphate; TPA, 12-O-tetradecanoyl phorbol-13-acetate. Note that there is a fundamental difference between the [Ca2+],-raising mechanism of platelet-derived growth factor (PDGH) (via IP3) and that of epidermal growth factor (EGF) (via Ca2+ entry). See text for details.

Another challenge for future studies is to examine whether the ionic signals generated by growth factor receptors have their correlates in the action of certain transforming oncogene products, some of which are known to be tyrosine-specific protein kinases. It is reasonable to speculate that malignant growth, induced by inappropriate expression of cellular proto-oncogenes, is partially the result of the continual production of second messengers like IP3 and diacylglycerol. This might lead to altered cellular Ca2+ pools and to constitutive activation of kinase C and, hence, of the Na+/H+ exchanger.

Research related to this review was supported by the Netherlands Cancer Foundation (Koningin Wilhelmina Fonds).

Aerts
,
R. J.
,
Durston
,
A. J.
&
Moolenaar
,
W. H.
(
1985
).
Cytoplasmic pH and the regulation of the Dictyostelium cell cycle
.
Cell
43
,
653
657
.
Aronson
,
P. S.
,
Nee
,
J.
&
Suhm
,
M. A.
(
1982
).
Modifier role of internal H+ in activating the Na-H exchanger in renal microvillus membrane vesicles
.
Nature, Lond
.
299
,
161
163
.
Berridge
,
M. J.
,
Heslop
,
J. P.
,
Irvine
,
R. F.
&
Brown
,
K. D.
(
1984
).
Inositol trisphosphate formation and calcium mobilization in Swiss 3T3 cells in response to PDGF
.
Biochem. J
.
222
.,
195
201
.
Berridge
,
M. J.
&
Irvine
,
R. F.
(
1984
).
Inositol trisphosphate, a novel second messenger in cellular signal transduction
.
Nature, Lond
.
312
,
315
321
.
Besterman
,
J. M.
,
May
,
W. S.
,
Levine
,
H.
,
Cragoe
,
E. J.
&
Cuatrecasas
,
P.
(
1985
).
Amiloride inhibits phorbol ester-stimulated Na+/H+ exchange and protein kianse C
.
J. biol. Chem
.
260
,
1155
1159
.
Bishop
,
J. M.
(
1985
).
Viral oncogenes
.
Cell
42
,
23
38
.
Bravo
,
R.
,
Burckhardt
,
J.
,
Curran
,
T.
&
Müller
,
R.
(
1985
).
Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes
.
EMBOJ
.
4
,
1193
1198
.
Busa
,
W. B.
&
Nuccitelli
,
R.
(
1984
).
Metabolic regulation via intracellular pH
.
Am. J. Physiol
.
246
,
R409
R438
.
Carpenter
,
G.
(
1984
).
Properties of the receptor for epidermal growth factor
.
Cell
37
,
357
358
.
Carpenter
,
G.
&
Cohen
,
S.
(
1979
).
Epidermal growth factor. A
.
Rev. Biochem
.
48
,
193
216
.
Cockroft
,
S.
&
Gomperts
,
B. D.
(
1985
).
Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase
.
Nature, Lond
.
314
,
534
536
.
Davis
,
R. J.
&
Czech
,
M. P.
(
1985
).
Amiloride directly inhibits growth factor receptor tyrosine kinase activity
.
J, biol. Chem
.
260
,
2543
2551
.
Defize
,
L. H. K.
,
Moolenaar
,
W. H.
,
Van Der Saag
,
P. T.
&
De Laat
,
S. W.
(
1986
).
Dissociation of cellular responses to epidermal growth factor using anti-receptor monoclonal antibodies
.
EMBOJ. (in press)
.
Doolittle
,
R. F.
,
Hunkapiller
,
M. W.
,
Hood
,
L. E.
,
Devare
,
S. G.
,
Robbins
,
K. C.
,
Aaronson
,
S. A.
&
Antionades
,
H. N.
(
1983
).
Simian sarcoma one gene, v-sis, is derived from the gene(s) encoding a platelet-derived growth factor
.
Science
221
,
275
277
.
Downward
,
J.
,
Yarden
,
Y.
,
Mayes
,
E.
,
Scrage
,
G.
,
Totty
,
N.
,
Stockwell
,
P.
,
Ullrich
,
A.
,
Schlessinger
,
J.
&
Waterfield
,
M. D.
(
1984
).
Close similarity of EGF receptor and v-erb-B oncogene protein sequences
.
Nature, Lond
.
307
,
521
527
.
Grinstein
,
S.
,
Cohen
,
S.
,
Goetz
,
J. D.
,
Rothstein
,
A.
&
Gelfand
,
E. W.
(
1985
).
Characterization of the activation of Na+/H+ exchange in lymphocytes by phorbol esters: change in cytoplasmic pH dependence of the antiport
.
Proc. natn. Acad. Sci. U.S.A
.
82
,
1429
1433
.
Heldin
,
C.-H.
&
Westermark
,
B.
(
1984
).
Growth factors: mechanism of action and relation to oncogenes
.
Cell
37
,
9
20
.
Hesketh
,
T. R.
,
Moore
,
J. P.
,
Morris
,
J. D. H.
,
Taylor
,
M. V.
,
Rogers
,
J.
,
Smith
,
G. A.
&
Metcalfe
,
J. C.
(
1985
).
A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cells
.
Nature, Lond
.
313
,
481
484
.
Horne
,
W. C.
,
Norman
,
N. E.
,
Schwartz
,
D. B.
&
Simons
,
E. R.
(
1981
).
Changes in cytoplasmic pH and in membrane potential in thrombin-stimulated human platelets
.
Eur. J. Biochem
.
120
,
295
302
.
Hülser
,
D. F.
&
Frank
,
W.
(
1971
).
Elektrophysiologische Messungen an dem Obenflachen-membranen
.
Z. Naturf
.
266
,
1045
1048
.
Hunter
,
T.
&
Cooper
,
J. A.
(
1985
).
Protein-tyrosine kinases. A
.
Rev. Biochem
.
54
,
897
930
.
Katada
,
T.
,
Gilman
,
A.
,
Watanabe
,
Y.
,
Bauer
,
S.
&
Jakobs
,
K. H.
(
1985
).
Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding component and apparently suppresses its function in hormonal inhibition of adenylate cyclase
.
Eur. J. Biochem
.
151
,
431
437
.
L’allemain
,
G.
,
Franchi
,
A.
,
Cragoe
,
E. J.
&
Pouysségur
,
J.
(
1984
).
Blockade of the Na+/H+ antiport abolishes growth factor-induced DNA synthesis in fibroblasts
.
J. biol. Chem
.
259
,
4313
4319
.
L’allemain
,
G.
,
Paris
,
S.
&
Pouysségur
,
J.
(
1985
).
Role of Na+-dependent Cr/HCO3 exchange in regulation of intracellular pH in fibroblasts
.
J, biol. Chem
.
260
,
4877
4883
.
Molski
,
T. F. P.
,
Naccache
,
P. H.
,
Volpi
,
M.
,
Wolpert
,
L. M.
&
Sha’afi
,
R. I.
(
1980
).
Specific modulation of the intracellular pH of rabbit neutrophils by chemotactic factors
.
Biochem. biophys. Res. Commun
.
94
,
508
514
.
Moolenaar
,
W. H.
(
1986a
).
Effects of growth factors on intracellular pH regulation. A
.
Rev. Physiol
.
48
,
363
376
.
Moolenaar
,
W. H.
(
1986b
).
Regulation of cytoplasmic pH by Na+/H+ exchange
.
Trends biochem. Sci. (in press)
.
Moolenaar
,
W. H.
,
Aerts
,
R. J.
,
Tertoolen
,
L. G. J.
&
De Laat
,
S. W.
(
1986
).
The epidermal growth factor-induced calcium signal in A431 cells
.
J. biol. Chem
.
261
,
279
284
.
Moolenaar
,
W. H.
,
Boonstra
,
J.
,
Van Der Saag
,
P. T.
&
De Laat
,
S. W.
(
1981a
).
Sodium/ proton exchange in mouse neuroblastoma cells
.
J. biol. Chem
.
256
,
12883
12887
.
Moolenaar
,
W. H.
,
De Laat
,
S. W.
&
Vander Saag
,
P. T.
(
1979
).
Serum triggers a sequence of rapid ionic conductance changes in quiescent neuroblastoma cells
.
Nature, Lond
.
279
,
721
723
.
Moolenaar
,
W. H.
,
Mummery
,
C. L.
,
Van Der Saag
,
P. T.
&
De Laat
,
S. W.
(
1981b
).
Rapid ionic events and the initiation of growth in serum-stimulated neuroblastoma cells
.
Cell
23
,
789
798
.
Moolenaar
,
W. H.
,
Tertoolen
,
L. G. J.
&
De Laat
,
S. W.
(
1984
).
Growth factors immediately raise cytoplasmic free Ca2+ in human fibroblasts
.
J. biol. Chem
.
259
,
8066
8069
.
Moolenaar
,
W. H.
,
Yarden
,
Y.
,
De Laat
,
S. W.
&
Schlessinger
,
J.
(
1982
).
Epidermal growth factor induces electrically silent Na+ influx in human fibroblasts
.
J. biol. Chem
.
257
,
8502
8506
.
Moolenaar
,
W. H.
,
Tsien
,
R. Y.
,
Van Der Saag
,
P. T.
&
De Laat
,
S. W.
(
1983
).
Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts
.
Nature, Lond
.
304
,
645
648
.
Nishizuka
,
Y.
(
1984
).
The role of protein kinase C in cell surface signal transduction and tumour promotion
.
Nature, Lond
.
308
,
693
698
.
Ohsako
,
S.
&
Deguchi
,
T.
(
1981
).
Stimulation by phosphatidic acid of calcium influx and cyclic GMP synthesis in neuroblastoma cells
.
J. biol. Chem
.
256
,
10945
10948
.
Paris
,
S.
&
Pouysségur
,
J.
(
1984
).
Growth factors activate the Na+/H+ antiporter in quiescent fibroblasts by increasing its affinity for intracellular H+
.
J. biol. Chem
.
259
,
10989
10994
.
Paris
,
S.
&
Pouysségur
,
J.
(
1986
).
Pertussis toxin inhibits thrombin-induced activation of phosphoinositide hydrolysis and Na+/H+ exchange in hamster fibroblasts
.
EMBOJ
.
5
,
55
60
.
Pouysségur
,
J.
,
Franchi
,
A.
,
L’allemain
,
G.
&
Paris
,
S.
(
1985
).
Cytoplasmic pH, a key determinant of growth factor-induced DNA synthesis in quiescent fibroblasts
.
FEBS Letts
190
,
115
118
.
Pouysségur
,
J.
,
Sardet
,
C.
,
Franchi
,
A.
,
L’allemain
,
G.
&
Paris
,
S.
(
1984
).
A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH
.
Proc. natn. Acad. Sci. U.S.A
.
81
,
4833
4837
.
Putney
,
J. W.
,
Weiss
,
S. J.
, VAN
De Walle
,
C. M.
&
Haddas
,
R. A.
(
1980
).
Is phosphatidic acid a calcium ionophore under neurohumoral control?
Nature, Lond
.
284
,
345
347
.
Roos
,
A.
&
Boron
,
W.
(
1981
).
Intracellular pH
.
Physiol. Rev
.
61
,
296
434
.
Rothenberg
,
P.
,
Reuss
,
L.
&
Glaser
,
L.
(
1982
).
Serum and EGF transiently depolarize quiescent BSC-1 epithelial cells
.
Proc. natn. Acad. Sci. U.S.A
.
79
,
7783
7787
.
Rozengurt
,
E.
(
1981
).
Stimulation of Na+ influx, Na+,K+ pump activity and DNA synthesis in quiescent cultured cells
.
Adv. Enzyme Regulation
19
,
61
85
.
Sagi-Eisenberg
,
R.
,
Lieman
,
H.
&
Pecht
,
I.
(
1985
).
Protein kinase C regulation of the receptor-coupled calcium signal in histamine-secreting rat basophilic leukaemia cells
.
Nature, Lond
.
313
,
59
60
.
Sahai
,
A.
,
Smith
,
K. B.
,
Pannerselvam
,
M.
&
Salomon
,
D. S.
(
1982
).
Activation of calcium and phospholipid-dependent protein kinase by EGF in A431 cells
.
Biochem. biophys. Res. Commun
.
109
,
11206
11214
.
Sawyer
,
S. T.
&
Cohen
,
S.
(
1981
).
Enhancement of calcium uptake and phosphatidylinositol turnover by EGF in A431 cells
.
Biochemistry NY
20
,
6280
6286
.
Serhan
,
C. N.
,
Fridovich
,
J.
,
Goetzl
,
E. J.
,
Dunham
,
P.
&
Weissmann
,
G.
(
1982
).
Leukotriene B4 and phosphatidic acid are calcium ionophores
.
J. biol. Chem
.
257
,
4746
4752
.
Tsuda
,
T.
,
Kaibuchi
,
K.
,
West
,
B.
&
Takai
,
Y.
(
1985
).
Involvement of Ca2+ in platelet-derived growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts
.
FEBS Letts
187
,
43
46
.
Vara
,
F.
&
Rozengurt
,
E.
(
1985
).
Stimulation of Na+/H+ antiport activity by EGF and insulin occurs without activation of protein kinase C
.
Biochem. biophys. Res. Commun
.
130
,
646
653
.
Waterfield
,
M. D.
,
Scrace
,
G. T.
,
Whittle
,
N.
,
Stroobant
,
P.
,
Johnson
,
A.
,
Wasteson
,
A.
,
Westermark
,
B.
,
Heldin
,
C.-H.
,
Huang
,
J. S.
&
Deuel
,
T. F.
(
1983
).
Platelet-derived growth factor is structurally related to the putative transforming protein of simian sarcoma virus
.
Nature, Lond
.
304
,
35
39
.
Westermark
,
B.
,
Heldin
,
C.-H.
,
Ek
,
B.
,
Johnson
,
A.
,
Mellstrom
,
K.
,
Nistér
,
M.
&
Wasteson
,
A.
(
1983
).
Biochemistry and biology of platelet-derived growth factor
.
In Growth and Maturation Factors
, vol.
1
(ed.
G.
Guroff
), pp.
75
115
.
New York
:
Wiley
.
Whitaker
,
M. J.
&
Steinhardt
,
R. A.
(
1982
).
Ionic regulation of egg activation
.
Q. Rev. Biophys
.
15
,
593
666
.
Whiteley
,
B.
,
Cassel
,
D.
,
Zhuang
,
Y.
&
Glaser
,
L.
(
1984
).
The tumor promoter 12-myristate 13-acetate inhibits mitogen-stimulated Na+/H+ exchange in human epidermoid carcinoma A431 cells
.
J. Cell Biol
.
99
,
1162
1166
.
Zhuang
,
Y.
,
Cragoe
,
E. J.
,
Shaikewitz
,
T.
,
Glaser
,
L.
&
Cassel
,
D.
(
1984
).
Characterization of potent Na+/H+ exchange inhibitors of the amiloride series in A431 cells
.
Biochemistry NY
23
,
4481
4488
.